Get the Stockscreener App
2.77
0.00%
0.00
Sensus Healthcare Inc stock is traded at $2.77, with a volume of 12,827.
It is up +0.00% in the last 24 hours and down -9.77% over the past month.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
See More
Previous Close:
$2.77
Open:
$2.73
24h Volume:
12,827
Relative Volume:
0.78
Market Cap:
$45.60M
Revenue:
$22.53M
Net Income/Loss:
$-7.77M
P/E Ratio:
-5.834
EPS:
-0.4748
Net Cash Flow:
$-740.00K
1W Performance:
-6.10%
1M Performance:
-9.77%
6M Performance:
-37.61%
1Y Performance:
-16.31%
1-Day Range:
$2.73
$2.835
1-Week Range:
$2.71
$3.005
52-Week Range:
$2.66
$5.49
Sensus Healthcare Inc Stock (SRTS) Company Profile
Name
Sensus Healthcare Inc
Sector
Industry
Phone
561-922-5808
Address
851 BROKEN SOUND PARKWAY NW, BOCA RATON, FL
Compare SRTS vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRTS
Sensus Healthcare Inc
|
2.77 | 45.60M | 22.53M | -7.77M | -740.00K | -0.4748 |
ABT
Abbott Laboratories
|
104.89 | 181.50B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.75 | 121.20B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.66 | 113.02B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.39 | 64.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sensus Healthcare Inc Stock (SRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Initiated | Alliance Global Partners | Buy |
| Jan-31-25 | Initiated | Lake Street | Buy |
| Nov-15-24 | Reiterated | Maxim Group | Buy |
| Feb-26-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Dec-16-20 | Downgrade | Northland Capital | Outperform → Market Perform |
| Aug-10-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Feb-14-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Nov-07-19 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jan-29-19 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-26-18 | Initiated | B. Riley FBR | Buy |
| Nov-03-17 | Reiterated | Maxim Group | Buy |
| Jun-06-17 | Initiated | Maxim Group | Buy |
| Aug-08-16 | Initiated | Northland Capital | Outperform |
View All
Sensus Healthcare Inc Stock (SRTS) Latest News
Q2 2026 Sensus Healthcare Inc Earnings Call Transcript - GuruFocus
Sensus Healthcare Inc. Company & People | 5TX - Barron's
Sensus Healthcare Launches Treat Skin Cancer to Empower Patients Navigating Non-Melanoma Skin Cancer - EIN News
Sensus Healthcare Inc. Advanced Charts | 5TX - Barron's
Sensus Healthcare Stock Price Forecast. Should You Buy SRTS? - StockInvest.us
Sachetta Eric Acquires 64,841 Shares of Sensus Healthcare at $3.44-$3.54 (NASDAQ: SRTS) - Kalkine Media
Sensus Healthcare (NASDAQ: SRTS) director buys more shares under $3.55 - Stock Titan
Sensus Healthcare director Eric Sachetta buys $66,682 in stock By Investing.com - Investing.com South Africa
Sensus Healthcare director Eric Sachetta buys $66,682 in stock - Investing.com
Sensus Healthcare director Eric Sachetta buys $66,682 in stock By Investing.com - Investing.com Australia
Sensus Healthcare director Eric Sachetta buys $66,682 in stock By Investing.com - Investing.com India
Sensus Healthcare director Eric Sachetta buys $66,682 in stock By Investing.com - Investing.com UK
Sensus Healthcare's Eric Sachetta Acquires 20% More Stock - Sahm
Sensus Healthcare's Eric Sachetta Acquires 20% More Stock - simplywall.st
Sensus Healthcare's Eric Sachetta Acquires 20% More Stock - Moomoo
3 Promising Penny Stocks With Over $50M Market Cap - simplywall.st
Sensus Healthcare director Eric Sachetta buys $112,904 in stock - Investing.com
Sensus Healthcare director Eric Sachetta buys $112,904 in stock By Investing.com - Investing.com Nigeria
Sensus Healthcare director Eric Sachetta buys $112,904 in stock By Investing.com - Investing.com UK
Sensus Healthcare (SRTS) director adds 31K shares - Stock Titan
Sensus Healthcare Reports Q2 2026 Financial Results with Significant Revenue Decline - Intellectia AI
Sensus (SRTS) Q2 2026 Earnings Call Transcript - The Globe and Mail
Sensus Healthcare revenues down 68.5% to USD 2.3M in Q2 2026 - Medical Buyer
Freedom sees more than 100% upside potential in Sensus Healthcare shares - Freedom Broker
A. G. P. Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Cuts Target Price to $5.5 - Moomoo
SRTS Q2 2026 Earnings: Wider-Than-Expected Loss Sends Shares Down 9.5%Low Estimate Range - vinanet.vn
Sensus Healthcare Inc (SRTS) (Q2 2026) Earnings Call Highlights: Strong Pipeline and New CPT ... - Yahoo Finance
SRTS Q2 2026 Earnings: Wider-Than-Expected Loss Sends Shares Down 9.5%Earnings Season Preview - https://www.dars.gov.et/
Sensus Healthcare (SRTS) Q2 2026 Earnings: EPS Misses Estimate by 41.18%; Shares Fall 9.49%Earnings Expansion Phase - dars.gov.et
Q2 2026 Sensus Healthcare Inc Earnings Call Transcript - GuruFocus
SRTS Maintained by Lake Street -- Price Target Lowered to $4.00 - GuruFocus
Sensus Healthcare, Inc. Q2 2026: Revenue $2.29M, EPS $(0.53) — 10-Q Summary - TradingView
Lake Street Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Cuts Target Price to $4 - Moomoo
Sensus Healthcare, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Applied Materials, Globant And 3 Stocks To Watch Heading Into Friday - Benzinga
SRTS Looks 15.9% Overvalued on GF Value™ - GuruFocus
Sensus Healthcare Q2 Earnings Call Highlights - MarketBeat
Sensus Healthcare Q2 Earnings Call Highlights - TradingView
Sensus Healthcare Q2 Earnings Call Highlights - Yahoo Finance
Sensus Healthcare Q2 EPS $(0.53) misses estimate; sales fall 69% - scanx.trade
Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Expectations By $0.41 EPS - MarketBeat
Earnings call transcript: Sensus Healthcare posts Q2 2026 miss, shares fall after hours - Investing.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Sensus Healthcare Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Full Transcript: Sensus Healthcare Q2 2026 Earnings Call - Benzinga
SENSUS HEALTHCARE ($SRTS) Releases Q2 2026 Earnings - Quiver Quantitative
Sensus Healthcare Inc (SRTS) Faces Challenges in Q2 Earnings: Re - GuruFocus
Sensus Healthcare Q2 revenue misses estimates as unit sales fall - TradingView
SRTS: Q2 2026 revenue dropped 68.5% year-over-year, but commercial momentum and pipeline remain strong - TradingView
Sensus Healthcare Q2 Adjusted Ebitda USD -3.0 - Moomoo
Sensus Healthcare Inc Stock (SRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sensus Healthcare Inc Stock (SRTS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sachetta Eric | Director |
Aug 31 '26 |
Buy |
3.54 |
27,304 |
96,602 |
294,784 |
| Sachetta Eric | Director |
Aug 27 '26 |
Buy |
3.18 |
10,925 |
34,752 |
229,943 |
| Sachetta Eric | Director |
Aug 26 '26 |
Buy |
3.29 |
9,708 |
31,930 |
219,018 |
| Sachetta Eric | Director |
Aug 24 '26 |
Buy |
3.25 |
34,697 |
112,904 |
209,310 |
| Sachetta Eric | Director |
Aug 21 '26 |
Buy |
3.25 |
7,000 |
22,778 |
174,613 |
| Sachetta Eric | Director |
Aug 20 '26 |
Buy |
3.13 |
24,000 |
75,072 |
167,613 |
| Sardano Joseph C | CHIEF EXECUTIVE OFFICER |
Aug 20 '26 |
Buy |
3.02 |
20,000 |
60,486 |
1,220,293 |
| Sachetta Eric | Director |
May 12 '26 |
Buy |
3.33 |
1,500 |
5,002 |
143,613 |
| Sachetta Eric | Director |
Feb 24 '26 |
Buy |
3.81 |
2,000 |
7,620 |
142,113 |
| Sachetta Eric | Director |
Nov 21 '25 |
Buy |
3.93 |
7,000 |
27,510 |
140,113 |
3.47%
3.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):